End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
828 INR | +0.82% | -0.65% | +26.01% |
May. 15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
Apr. 25 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.01% | 1.22B | |
+32.36% | 694B | |
+29.95% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.45% | 239B | |
-3.35% | 209B | |
+10.05% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- GLS Stock
- News Glenmark Life Sciences Limited
- Glenmark Life Signs Master Supply Agreement with Japanese Drugmaker for Urinary Anti-Spasmodic API